XML 76 R80.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details) (USD $)
0 Months Ended 0 Months Ended
Jun. 07, 2012
Mar. 31, 2012
Dec. 31, 2013
Orthotec LLC, Litigation Settlement [Member]
Mar. 15, 2014
Subsequent Event [Member]
Orthotec LLC, Litigation Settlement [Member]
Mar. 15, 2014
Subsequent Event [Member]
By March 31, 2014 [Member]
Orthotec LLC, Litigation Settlement [Member]
Mar. 15, 2014
Subsequent Event [Member]
By April 11, 2014 [Member]
Orthotec LLC, Litigation Settlement [Member]
Mar. 15, 2014
Subsequent Event [Member]
Beginning Fourth Quarter of 2014 [Member]
Orthotec LLC, Litigation Settlement [Member]
Installment
Mar. 19, 2014
Deerfield [Member]
Subsequent Event [Member]
Mar. 17, 2014
Deerfield [Member]
Subsequent Event [Member]
Mar. 17, 2014
Maximum [Member]
Deerfield [Member]
Subsequent Event [Member]
Mar. 15, 2014
Healthpoint Capital [Member]
Subsequent Event [Member]
Orthotec LLC, Litigation Settlement [Member]
Subsequent Event [Line Items]                      
Litigation settlement, amount       $ 49,000,000 $ 1,750,000 $ 15,750,000 $ 31,500,000        
Length of period after closing a financing for the Company to make additional settlement payment           25 days          
Litigation settlement, number of quarterly installments             28        
Litigation settlement, quarterly installments, amount             1,100,000        
Litigation settlement, contribution by entity involved                     5,000,000
Litigation settlement interest rate             7.00%        
Litigation settlement interest, quarterly installments, amount             1,100,000        
Litigation settlement accrual     46,200,000                
Maximum borrowing capacity 50,000,000               50,000,000    
Aggregate amount of draw down for working capital                 15,000,000    
Increment amount of draw down for general corporate purposes                 2,500,000.0    
Transaction fee as percentage of principal amount                 2.50%    
Facility agreement stated interest rate                 8.75%    
Purchase of common stock shares for issuance of warrants   500,000             6,250,000    
Exercise price of warrants   2.50           1.39 1.39    
Number of common stock called by warrants or rights associated with each disbursement borrowing                   10,000,000  
Number of days following borrowing request to determine exercise price associated with each disbursement borrowing under Facility Agreement                 15 days    
Net proceeds from initial draw under Facility Agreement               $ 19,500,000      
Number of warrants issued               4,000,000